Avized overview
What Amperos does
End-to-end AI denial management — portal navigation, payer calls, corrected claims, appeals, all autonomous $16M Series A led by Bessemer, 3,000+ clinical locations, $700M revenue recovered/year First AI-native end-to-end denial management platform
Avized Pro buying intelligence
Turn this profile into a buying decision.
Pro adds buyer-ready fit, commercial signals, implementation diligence, evidence, and sources.
Core features
3 tracked features
Show
Core features
3 tracked features
Avized research
Denial management and appeals
Electronic claims submission
Automated payer phone calls
Pricing
Subscription
Details
Pricing
Subscription
Contact for pricing
What to evaluate
Open
Denial management ROI depends on appeal win rate and speed of response. Evaluate the platform's performance on your most common denial codes before committing.
Avized facilitates vendor introductions. Referral relationships never affect rankings.